Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations are in order for Associate Professor Samira Lakhal-Littleton, who has been awarded a Senior Non-Clinical Fellowship by the Medical Research Council to further her lab's work exploring the implications of the cardiac hepcidin/ferroportin axis for the management of iron deficiency in heart failure.

Samira Lakhal-LittletonOver the past six years, research in the Lakhal-Littleton lab has uncovered the mechanisms and importance of local iron control in the heart, lung, kidney and fetal liver. In 2016, the lab published the first study describing the mechanism linking iron deficiency with heart disease. In 2019, the lab revealed a critical link between iron deficiency and pulmonary arterial hypertension (PAH), finding that iron deficiency within the smooth muscle cells of the pulmonary arteries is in itself sufficient to cause PAH, even in the absence of anaemia. This year, the lab challenged assumptions on fetal iron development during pregnancy by revealing that fetal liver hepcidin plays a key role in determining iron endowment in the newborn baby, demonstrating that medical advice given to pregnant women, particularly around iron supplements, should take fetal iron levels into account, not just the mother's haemoglobin levels.

These discoveries and more have changed our understanding of the pathophysiology of iron deficiency of chronic disease, and have important implications for the management of iron deficiency in patients with chronic conditions such as chronic heart failure, chronic kidney disease and chronic obstructive pulmonary disease.

Associate Professor Samira Lakhal-Littleton has now been awarded an MRC Senior Non-Clinical Fellowship to further the cardiovascular aspect of her lab's work. The award will enable her team to work to understand how the iron homeostatic hormone hepcidin, which tends to be elevated in early stages of heart failure, modifies both the course of disease and the outcome of the iron treatment used to correct iron deficiency in heart failure patients.

 

This fellowship provides significant support over 5 years, to help translate the basic understanding gained thus far into better management of iron deficiency in patients with heart failure. - Prof Lakhal-Littleton

The Senior Non-Clinical Fellowships are designed to facilitate independent researchers with a track record of effectively leading their own research to become internationally recognised leaders in their field. More information on the Fellowship can be found on the Medical Research Council website.

Similar stories

Just over half of British Indians would take COVID vaccine

EDI News Outreach Postdoctoral Publication Research Riley Group News

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.

Earliest origins of the forming heart identified

Cardiac Theme Postdoctoral Publication Research

The earliest known progenitor of the outermost layer of the heart has been characterised for the first time and linked to the development of other critical cell types in the developing heart in a new paper from the Srinivas group led by BHF Immediate Fellow Dr Richard Tyser.

Lukas Krone to represent Oxford at the Global Young Scientists Summit

Awards and Honours EDI News Head of Department's News Students Vyazovskiy Group News

Congratulations are in order for Dr Lukas Krone who is one of just five University of Oxford researchers selected to attend the Global Young Scientists Summit 2021.

New MRI technique could detect early signs of heart failure in cancer patients following chemotherapy

Cardiac Theme Postdoctoral Publication Research

New research led by Oxford BHF CRE Intermediate Transition Fellow Dr Kerstin Timm shows that a recently developed imaging technique pioneered by the Tyler Group can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.

Two major BHF awards to Neil Herring pave the way to new treatments for heart attack patients

Awards and Honours Cardiac Theme Herring Group News

Associate Professor Neil Herring has been awarded a Senior Clinical Research Fellowship and a Project grant from the British Heart Foundation to further critical research into the mechanisms behind heart attacks and heart failure and potential drugs to combat them. Given the 50% reduction in research investment this year from the BHF due to the impact of COVID-19, Prof Herring is to be congratulated on these awards.